Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C Clifford

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|May 28, 2016
DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomasJennie N Jeyapalan, Gabriel T Doctor, Tania A Jones, et al.
Neuro-Oncology|October 8, 2024
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastomaMagretta Adiamah, Bethany Poole, Janet C Lindsey, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Acta Neuropathologica|November 12, 2013
Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour typesEd C Schwalbe, James T Hayden, Hazel A Rogers, et al.
Acta Neuropathologica Communications|November 21, 2013
Identification of a neuronal transcription factor network involved in medulloblastoma developmentMaria Lastowska, Hani Al-Afghani, Haya H Al-Balool, et al.
Genes & Development|November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formationTamar Uziel, Frederique Zindy, Suqing Xie, et al.
Nature Communications|August 30, 2020
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunityYura Grabovska, Alan Mackay, Patricia O'Hare, et al.
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|May 28, 2016
DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomasJennie N Jeyapalan, Gabriel T Doctor, Tania A Jones, et al.
Neuro-Oncology|October 8, 2024
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastomaMagretta Adiamah, Bethany Poole, Janet C Lindsey, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Acta Neuropathologica Communications|January 11, 2023
Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imagingFranziska Linke, James E C Johnson, Stefanie Kern, et al.
Acta Neuropathologica|November 12, 2013
Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour typesEd C Schwalbe, James T Hayden, Hazel A Rogers, et al.
Acta Neuropathologica Communications|November 21, 2013
Identification of a neuronal transcription factor network involved in medulloblastoma developmentMaria Lastowska, Hani Al-Afghani, Haya H Al-Balool, et al.
Genes & Development|November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formationTamar Uziel, Frederique Zindy, Suqing Xie, et al.
Nature Communications|August 30, 2020
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunityYura Grabovska, Alan Mackay, Patricia O'Hare, et al.
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Acta Neuropathologica|April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratificationJack Goddard, Jemma Castle, Emily Southworth, et al.
Pageof 13